• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity

tetano

Editor, Senior Moderator
FEBS J. 2013 Aug 26. doi: 10.1111/febs.12503. [Epub ahead of print]
Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity.
Ou JL, Mizushina Y, Wang SY, Chuang DY, Nadar M, Hsu WL.
Source

Graduate Institute of Microbiology and Public Health, National Chung Hsing University, 250 Kuo Kuang Road, Taichung, 402, Taiwan.
Abstract

Curcumin is a commonly used colouring agent and spice in food. Previously, we reported curcumin inhibits type A influenza virus (IAV) infection by interfering with the viral HA activity. To search for a stable curcumin analogue with potent anti-IAV activity and to investigate the structure contributing to its anti-IAV activity, a comparative analysis of structural and functional analogues of curcumin (Cur), such as tetrahydrocurcumin (THC), and petasiphenol (Pet), was performed in the current study. The result of time-of-drug addition tests indicated that these curcuminoids were able to inhibit IAV production in cell cultures. Noticeably, Pet and THC inhibit IAV to a less extent than curcumin that in line with their effect on reducing plaque formation when IAV was treated with curcumin analogues prior to infection. Surprisingly, both THC and Pet did not harbour HA inhibitory effect. It should be noted that the structure of Pet and THC differs from curcumin in the number of double bonds present in the central seven-carbon chain, and structure modelling of curcumin analogues indicates that the conformations of THC and Pet are distinct from that of curcumin. Moreover, simulation docking of curcumin with HA structure revealed that curcumin binds to the region constituting Sialic acid anchoring residues that supports the results on HI assay. Collectively, structure-activity relationship analyses indicate that presence of the double bonds in the central seven-carbon chain enhanced the curcumin-dependent anti-IAV activity and curcumin might interfere with IAV entry by its interaction with the receptor binding region of viral HA protein. This article is protected by copyright. All rights reserved.

This article is protected by copyright. All rights reserved.
KEYWORDS:

Curcumin, influenza virus, petasiphenol, simulation docking, structure analogue, structure-activity relationship, tetrahydrocurcumin

PMID:
24034558
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24034558
 
Back
Top Bottom